Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure

Go back to Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure

Goldman Sachs on Microsoft (MSFT): 'Strong cash yields as CapEx growth slows can drive accelerating net interest income'

January 27, 2025 2:11 PM EST

Goldman Sachs analyst Kash Rangan reiterated a Buy rating and $500.00 price target on Microsoft (NASDAQ: MSFT)

The analyst comments "Microsofts -19% TTM vs. NASDAQ despite its pivotal Gen-AI infrastructure cycle and the percolation of Gen-AI into the platform and application layer, coupled with EPS leverage, reaffirms conviction in our Buy rating and $500 PT. While higher COGS, and FX... More

Raymond James Reiterates Strong Buy Rating on Microsoft (MSFT)

January 27, 2025 6:59 AM EST

Raymond James analyst Andrew Marok reiterated a Strong Buy rating and $480.00 price target on Microsoft (NASDAQ: MSFT)

The analyst comments "Microsoft reports F2Q25 results on Wednesday, January 29 after market close. Sentiment still leans positive on Microsoft with AI dominating conversations... More